Logo image of INSP

INSPIRE MEDICAL SYSTEMS INC (INSP) Stock News

NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD

127.18  -1.43 (-1.11%)

After market: 127.18 0 (0%)

INSP Latest News, Press Relases and Analysis

News Image
9 days ago - Zacks Investment Research

Is it Apt to Retain Omnicell Stock in Your Portfolio Now?

OMCL stays on investors' radar due to its strong 2025 growth targets with automation and tech services, but faces margin risks from macro and competitive headwinds.

Mentions: OMCL PBH PAHC

News Image
11 days ago - Zacks Investment Research

Inspire (INSP) Down 14.5% Since Last Earnings Report: Can It Rebound?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

News Image
13 days ago - Zacks Investment Research

Here's Why You Should Retain ICLR Stock in Your Portfolio Now

Investors remain optimistic about ICON, driven by its commitment to enhance clinical delivery by integrating AI and impressive strategic pacts.

Mentions: ICLR PBH PAHC

News Image
16 days ago - Inspire Medical Systems

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight

MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the...

News Image
17 days ago - Zacks Investment Research

Is Bio-Techne Stock the Right Pick for Your Portfolio Now?

TECH is gaining ground in cell and gene therapy, and with Ella, while navigating macro hurdles. Is it the right fit for your portfolio today?

Mentions: PBH TECH PAHC

News Image
19 days ago - Zacks Investment Research

Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock?

PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds.

Mentions: PBH STE PAHC

News Image
20 days ago - Zacks Investment Research

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.

Mentions: HSIC PBH PAHC

News Image
20 days ago - Zacks Investment Research

Insulet Gains 78.5% in a Year: What's Driving the Stock?

PODD's shares rise on the back of Omnipod 5's growth, global expansion, and strong Q1 2025 gains despite rising operating costs and macro headwinds.

Mentions: PBH PODD PAHC

News Image
24 days ago - Zacks Investment Research

Penumbra Rallies 35.9% in a Year: What's Driving the Stock?

PEN has shown notable strength over the past year, driven by the performance of its core U.S. thrombectomy business. Solid international prospects instill optimism.

Mentions: PBH PAHC PEN

News Image
24 days ago - Zacks Investment Research

Should Tandem Diabetes Stock Stay in Your Portfolio Now?

Investors remain optimistic about TNDM, courtesy of its strong t:slim X2 performance and breakthrough innovations.

Mentions: PBH PAHC TNDM

News Image
25 days ago - Zacks Investment Research

What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year?

DGX has shown notable strength in the past year, driven by robust core performance and contributions from acquisitions.

Mentions: DGX PBH PAHC

News Image
a month ago - Zacks Investment Research

Should You Continue to Hold Charles River Stock in Your Portfolio?

CRL stays on investors' radars due to the strength of partnerships and segmental prospects.

Mentions: CRL PBH PAHC

News Image
a month ago - Zacks Investment Research

Omnicell's New Perioperative Clinic Setting Products May Boost Stock

OMCL unveils new offerings for the perioperative and clinic setting.

Mentions: CAH OMCL HIMS

News Image
a month ago - Zacks Investment Research

All You Need to Know About Inspire (INSP) Rating Upgrade to Buy

Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

News Image
a month ago - Zacks Investment Research

Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know

The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

News Image
a month ago - Zacks Investment Research

INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts

Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.

Mentions: BSX CVS ITGR

News Image
a month ago - Zacks Investment Research

Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 143.48% and 3.20%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: TALK

News Image
a month ago - Inspire Medical Systems

Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook

Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter...

News Image
2 months ago - Inspire Medical Systems

Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors

MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the...

News Image
3 months ago - Inspire Medical Systems

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum

MINNEAPOLIS, March 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the...